Substituted arylamino -1,2,3,4-tetrahydro naphthalenes and -2,3-dihydro-1H-indenes as KCNQ activators

Inventors: Huanming Chen, Jean-Michel Vernier

Provisional Application Expired

	Code	Description	Pages	PDF
2006-06-05	`TRNA`	Transmittal of New Application	4	View
2006-06-05	`SPEC`	Specification	49	View
2006-06-05	`CLM`	Claims	6	View
2006-06-05	`ABST`	Abstract	1	View
2006-06-05	`WFEE`	Fee Worksheet (SB06)	1	View
2006-06-05	`ADS`	Application Data Sheet	3	View

Inventors

Huanming Chen Irvine, CA

Jean-Michel Vernier Laguna Niguel, CA

Attorneys & Agents of Record

HEIDI REESE Reg. 57841 Attorney · UNITED STATES PATENT AND TRADEMARK OFFICE

ROBERT KREBS Reg. 25885 Attorney · NIXON PEABODY LLP

DAVID RITCHIE Reg. 31562 Attorney · CANAANLAW, P. C.

KHALED SHAMI Reg. 38745 Attorney · VORYS, SATER SEYMOUR AND PEASE LLP

JOHN SCHAUB Reg. 42125 Attorney · NIXON PEABODY LLP

CHRISTOPHER OGDEN Reg. 44984 Attorney · KENYON & KENYON

AARON WININGER Reg. 45229 Attorney · SCHWEGMAN LUNDBERG & WOESSNER, P.A.

SUVASHIS BHATTACHARYA Reg. 46554 Attorney · LECLAIRRYAN

JENNIFER HAYES Reg. 50845 Attorney · NIXON PEABODY LLP

ANTHONY CANNING Reg. 62107 Agent · ARENT FOX LLP

Prosecution

VALEANT PHARMACEUTICALS INTERNATIONAL, VALEANT PHARMACEUTICALS NORTH AMERICA, CORIA LABORATORIES, LTD., DOW PHARMACEUTICAL SCIENCES, INC., ATON PHARMA, INC.

from GOLDMAN SACHS LENDING PARTNERS LLC

PATENT SECURITY RELEASE AGREEMENT Recorded 2011-03-14

GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT

from ATON PHARMA, INC., CORIA LABORATORIES, LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS INTERNATIONAL, VALEANT PHARMACEUTICALS NORTH AMERICA

SECURITY AGREEMENT Recorded 2010-10-04

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Pre-filled with this application's details

Quick Facts

External Links